EpiMass develops technology combining skin cancer diagnosis and treatment.
EpiMass has raised $646K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2026.
EpiMass's investors include BioInnovation Institute Venture Lab.
EpiMass is headquartered in Copenhagen, Denmark.
EpiMass develops technology combining skin cancer diagnosis and treatment.
EpiMass is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EpiMass — Funding & Investors." VCBacked, September 16, 2026, https://www.vcbacked.co/company/epimass. Accessed October 1, 2026.
VCBacked. (2026). EpiMass — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/epimass
{{cite web |title=EpiMass — Funding & Investors |url=https://www.vcbacked.co/company/epimass |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated